SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-115082
Filing Date
2024-10-16
Accepted
2024-10-16 17:25:21
Documents
96
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q celu-20240331.htm   iXBRL 10-Q 2596376
2 EX-10.22 celu-ex10_22.htm EX-10.22 29694
3 EX-31.1 celu-ex31_1.htm EX-31.1 16707
4 EX-31.2 celu-ex31_2.htm EX-31.2 16691
5 EX-32.1 celu-ex32_1.htm EX-32.1 10875
6 EX-32.2 celu-ex32_2.htm EX-32.2 10611
7 GRAPHIC img171534750_0.jpg GRAPHIC 8768
8 GRAPHIC img171534750_1.jpg GRAPHIC 19896
  Complete submission text file 0000950170-24-115082.txt   14648852

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT celu-20240331.xsd EX-101.SCH 2606360
99 EXTRACTED XBRL INSTANCE DOCUMENT celu-20240331_htm.xml XML 2723524
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38914 | Film No.: 241375428
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)